Pill That Hits A Cause Of Cystic Fibrosis Beats Expectations
More than 20 years after the gene behind cystic fibrosis was identified, a pill that could fix the problem in some people is getting closer to the reality.
The experimental medicine, taken twice a day, goes by the code name VX-770. Now there are some promising results from a study in 161 people with a specific genetic mutation that affects about 4 percent of cystic fibrosis patients.
More than 20 years after the gene behind cystic fibrosis was identified, a pill that could fix the problem in some people is getting closer to the reality.
The experimental medicine, taken twice a day, goes by the code name VX-770. Now there are some promising results from a study in 161 people with a specific genetic mutation that affects about 4 percent of cystic fibrosis patients.
